Markers of fibrosis in orbital tissues from patients graves’ orbitopathy: a retrospective cohort study
Authors:
- 23 December 2025
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 49 (4) , 777-785
Abstract
No abstract availableKeywords
Funding Information
- Università di Pisa (539901)
This publication has 15 references indexed in Scilit:
- Sirolimus for the treatment of Graves’ orbitopathyThyroid Research, 2025
- Teprotumumab for the Treatment of Active Thyroid Eye DiseaseNew England Journal of Medicine, 2020
- Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves OrbitopathyJAMA Ophthalmology, 2018
- Does Graves’ Orbitopathy Ever Disappear Answers to an Old QuestionEuropean Thyroid Journal, 2017
- TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy PathogenesisThe Journal of Clinical Endocrinology & Metabolism, 2016
- Current Insights into the Pathogenesis of Graves’ OphthalmopathyHormone and Metabolic Research, 2015
- Markers of Inflammation and Fibrosis in the Orbital Fat/Connective Tissue of Patients with Graves’ Orbitopathy: Clinical ImplicationsMediators of Inflammation, 2014
- Spontaneous Improvement of Untreated Mild Graves' Ophthalmopathy: Rundle's Curve RevisitedThyroid®, 2014
- Fibrotic disease and the TH1/TH2 paradigmNature Reviews Immunology, 2004
- An Update on “Special Stain” Histochemistry with Emphasis on AutomationAdvances in Anatomic Pathology, 2000